img

Global Rare Kidney Diseases Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Rare Kidney Diseases Treatment Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Rare Kidney Diseases Treatment Market
Global Rare Kidney Diseases Treatment market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Rare Kidney Diseases Treatment industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Rare Kidney Diseases Treatment market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Rare Kidney Diseases Treatment market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Aurinia Pharmaceuticals
Sanofi
Calliditas Therapeutics AB
Shire
GSK
Amicus Therapeutics
Horizon Therapeutics
Advicenne
Reata Pharmaceuticals
Alexion Pharmaceuticals
Otsuka Pharmaceutical
Segment by Type
Enzyme Replacement Therapy
Monoclonal Antibodies
Others

Segment by Application


Atypical Hemolytic Uremic Syndrome
Nephropathic Cystinosis
Lupus Nephritis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Rare Kidney Diseases Treatment introduction, etc. Rare Kidney Diseases Treatment Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Rare Kidney Diseases Treatment
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Kidney Diseases Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Enzyme Replacement Therapy
1.2.3 Monoclonal Antibodies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Rare Kidney Diseases Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Atypical Hemolytic Uremic Syndrome
1.3.3 Nephropathic Cystinosis
1.3.4 Lupus Nephritis
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rare Kidney Diseases Treatment Market Perspective (2018-2033)
2.2 Global Rare Kidney Diseases Treatment Growth Trends by Region
2.2.1 Rare Kidney Diseases Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Rare Kidney Diseases Treatment Historic Market Size by Region (2018-2023)
2.2.3 Rare Kidney Diseases Treatment Forecasted Market Size by Region (2024-2033)
2.3 Rare Kidney Diseases Treatment Market Dynamics
2.3.1 Rare Kidney Diseases Treatment Industry Trends
2.3.2 Rare Kidney Diseases Treatment Market Drivers
2.3.3 Rare Kidney Diseases Treatment Market Challenges
2.3.4 Rare Kidney Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Rare Kidney Diseases Treatment by Players
3.1.1 Global Rare Kidney Diseases Treatment Revenue by Players (2018-2023)
3.1.2 Global Rare Kidney Diseases Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Rare Kidney Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Rare Kidney Diseases Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Rare Kidney Diseases Treatment Market Concentration Ratio
3.4.1 Global Rare Kidney Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Kidney Diseases Treatment Revenue in 2022
3.5 Global Key Players of Rare Kidney Diseases Treatment Head office and Area Served
3.6 Global Key Players of Rare Kidney Diseases Treatment, Product and Application
3.7 Global Key Players of Rare Kidney Diseases Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Kidney Diseases Treatment Breakdown Data by Type
4.1 Global Rare Kidney Diseases Treatment Historic Market Size by Type (2018-2023)
4.2 Global Rare Kidney Diseases Treatment Forecasted Market Size by Type (2024-2033)
5 Rare Kidney Diseases Treatment Breakdown Data by Application
5.1 Global Rare Kidney Diseases Treatment Historic Market Size by Application (2018-2023)
5.2 Global Rare Kidney Diseases Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Rare Kidney Diseases Treatment Market Size (2018-2033)
6.2 North America Rare Kidney Diseases Treatment Market Size by Type
6.2.1 North America Rare Kidney Diseases Treatment Market Size by Type (2018-2023)
6.2.2 North America Rare Kidney Diseases Treatment Market Size by Type (2024-2033)
6.2.3 North America Rare Kidney Diseases Treatment Market Share by Type (2018-2033)
6.3 North America Rare Kidney Diseases Treatment Market Size by Application
6.3.1 North America Rare Kidney Diseases Treatment Market Size by Application (2018-2023)
6.3.2 North America Rare Kidney Diseases Treatment Market Size by Application (2024-2033)
6.3.3 North America Rare Kidney Diseases Treatment Market Share by Application (2018-2033)
6.4 North America Rare Kidney Diseases Treatment Market Size by Country
6.4.1 North America Rare Kidney Diseases Treatment Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Rare Kidney Diseases Treatment Market Size by Country (2018-2023)
6.4.3 North America Rare Kidney Diseases Treatment Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Rare Kidney Diseases Treatment Market Size (2018-2033)
7.2 Europe Rare Kidney Diseases Treatment Market Size by Type
7.2.1 Europe Rare Kidney Diseases Treatment Market Size by Type (2018-2023)
7.2.2 Europe Rare Kidney Diseases Treatment Market Size by Type (2024-2033)
7.2.3 Europe Rare Kidney Diseases Treatment Market Share by Type (2018-2033)
7.3 Europe Rare Kidney Diseases Treatment Market Size by Application
7.3.1 Europe Rare Kidney Diseases Treatment Market Size by Application (2018-2023)
7.3.2 Europe Rare Kidney Diseases Treatment Market Size by Application (2024-2033)
7.3.3 Europe Rare Kidney Diseases Treatment Market Share by Application (2018-2033)
7.4 Europe Rare Kidney Diseases Treatment Market Size by Country
7.4.1 Europe Rare Kidney Diseases Treatment Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Rare Kidney Diseases Treatment Market Size by Country (2018-2023)
7.4.3 Europe Rare Kidney Diseases Treatment Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Rare Kidney Diseases Treatment Market Size (2018-2033)
8.2 China Rare Kidney Diseases Treatment Market Size by Type
8.2.1 China Rare Kidney Diseases Treatment Market Size by Type (2018-2023)
8.2.2 China Rare Kidney Diseases Treatment Market Size by Type (2024-2033)
8.2.3 China Rare Kidney Diseases Treatment Market Share by Type (2018-2033)
8.3 China Rare Kidney Diseases Treatment Market Size by Application
8.3.1 China Rare Kidney Diseases Treatment Market Size by Application (2018-2023)
8.3.2 China Rare Kidney Diseases Treatment Market Size by Application (2024-2033)
8.3.3 China Rare Kidney Diseases Treatment Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Rare Kidney Diseases Treatment Market Size (2018-2033)
9.2 Asia Rare Kidney Diseases Treatment Market Size by Type
9.2.1 Asia Rare Kidney Diseases Treatment Market Size by Type (2018-2023)
9.2.2 Asia Rare Kidney Diseases Treatment Market Size by Type (2024-2033)
9.2.3 Asia Rare Kidney Diseases Treatment Market Share by Type (2018-2033)
9.3 Asia Rare Kidney Diseases Treatment Market Size by Application
9.3.1 Asia Rare Kidney Diseases Treatment Market Size by Application (2018-2023)
9.3.2 Asia Rare Kidney Diseases Treatment Market Size by Application (2024-2033)
9.3.3 Asia Rare Kidney Diseases Treatment Market Share by Application (2018-2033)
9.4 Asia Rare Kidney Diseases Treatment Market Size by Region
9.4.1 Asia Rare Kidney Diseases Treatment Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Rare Kidney Diseases Treatment Market Size by Region (2018-2023)
9.4.3 Asia Rare Kidney Diseases Treatment Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Aurinia Pharmaceuticals
11.1.1 Aurinia Pharmaceuticals Company Details
11.1.2 Aurinia Pharmaceuticals Business Overview
11.1.3 Aurinia Pharmaceuticals Rare Kidney Diseases Treatment Introduction
11.1.4 Aurinia Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.1.5 Aurinia Pharmaceuticals Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Rare Kidney Diseases Treatment Introduction
11.2.4 Sanofi Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.2.5 Sanofi Recent Developments
11.3 Calliditas Therapeutics AB
11.3.1 Calliditas Therapeutics AB Company Details
11.3.2 Calliditas Therapeutics AB Business Overview
11.3.3 Calliditas Therapeutics AB Rare Kidney Diseases Treatment Introduction
11.3.4 Calliditas Therapeutics AB Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.3.5 Calliditas Therapeutics AB Recent Developments
11.4 Shire
11.4.1 Shire Company Details
11.4.2 Shire Business Overview
11.4.3 Shire Rare Kidney Diseases Treatment Introduction
11.4.4 Shire Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.4.5 Shire Recent Developments
11.5 GSK
11.5.1 GSK Company Details
11.5.2 GSK Business Overview
11.5.3 GSK Rare Kidney Diseases Treatment Introduction
11.5.4 GSK Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.5.5 GSK Recent Developments
11.6 Amicus Therapeutics
11.6.1 Amicus Therapeutics Company Details
11.6.2 Amicus Therapeutics Business Overview
11.6.3 Amicus Therapeutics Rare Kidney Diseases Treatment Introduction
11.6.4 Amicus Therapeutics Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.6.5 Amicus Therapeutics Recent Developments
11.7 Horizon Therapeutics
11.7.1 Horizon Therapeutics Company Details
11.7.2 Horizon Therapeutics Business Overview
11.7.3 Horizon Therapeutics Rare Kidney Diseases Treatment Introduction
11.7.4 Horizon Therapeutics Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.7.5 Horizon Therapeutics Recent Developments
11.8 Advicenne
11.8.1 Advicenne Company Details
11.8.2 Advicenne Business Overview
11.8.3 Advicenne Rare Kidney Diseases Treatment Introduction
11.8.4 Advicenne Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.8.5 Advicenne Recent Developments
11.9 Reata Pharmaceuticals
11.9.1 Reata Pharmaceuticals Company Details
11.9.2 Reata Pharmaceuticals Business Overview
11.9.3 Reata Pharmaceuticals Rare Kidney Diseases Treatment Introduction
11.9.4 Reata Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.9.5 Reata Pharmaceuticals Recent Developments
11.10 Alexion Pharmaceuticals
11.10.1 Alexion Pharmaceuticals Company Details
11.10.2 Alexion Pharmaceuticals Business Overview
11.10.3 Alexion Pharmaceuticals Rare Kidney Diseases Treatment Introduction
11.10.4 Alexion Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.10.5 Alexion Pharmaceuticals Recent Developments
11.11 Otsuka Pharmaceutical
11.11.1 Otsuka Pharmaceutical Company Details
11.11.2 Otsuka Pharmaceutical Business Overview
11.11.3 Otsuka Pharmaceutical Rare Kidney Diseases Treatment Introduction
11.11.4 Otsuka Pharmaceutical Revenue in Rare Kidney Diseases Treatment Business (2018-2023)
11.11.5 Otsuka Pharmaceutical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Rare Kidney Diseases Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Enzyme Replacement Therapy
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Others
Table 5. Global Rare Kidney Diseases Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Rare Kidney Diseases Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Rare Kidney Diseases Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Rare Kidney Diseases Treatment Market Share by Region (2018-2023)
Table 9. Global Rare Kidney Diseases Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Rare Kidney Diseases Treatment Market Share by Region (2024-2033)
Table 11. Rare Kidney Diseases Treatment Market Trends
Table 12. Rare Kidney Diseases Treatment Market Drivers
Table 13. Rare Kidney Diseases Treatment Market Challenges
Table 14. Rare Kidney Diseases Treatment Market Restraints
Table 15. Global Rare Kidney Diseases Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Rare Kidney Diseases Treatment Revenue Share by Players (2018-2023)
Table 17. Global Top Rare Kidney Diseases Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Kidney Diseases Treatment as of 2022)
Table 18. Global Rare Kidney Diseases Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Rare Kidney Diseases Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Rare Kidney Diseases Treatment, Headquarters and Area Served
Table 21. Global Key Players of Rare Kidney Diseases Treatment, Product and Application
Table 22. Global Key Players of Rare Kidney Diseases Treatment, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rare Kidney Diseases Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Rare Kidney Diseases Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Rare Kidney Diseases Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Rare Kidney Diseases Treatment Revenue Market Share by Type (2024-2033)
Table 28. Global Rare Kidney Diseases Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Rare Kidney Diseases Treatment Revenue Share by Application (2018-2023)
Table 30. Global Rare Kidney Diseases Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Rare Kidney Diseases Treatment Revenue Share by Application (2024-2033)
Table 32. North America Rare Kidney Diseases Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Rare Kidney Diseases Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Rare Kidney Diseases Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Rare Kidney Diseases Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Rare Kidney Diseases Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Rare Kidney Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Rare Kidney Diseases Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Rare Kidney Diseases Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Rare Kidney Diseases Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Rare Kidney Diseases Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Rare Kidney Diseases Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Rare Kidney Diseases Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Rare Kidney Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Rare Kidney Diseases Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Rare Kidney Diseases Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Rare Kidney Diseases Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Rare Kidney Diseases Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Rare Kidney Diseases Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Rare Kidney Diseases Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Rare Kidney Diseases Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Rare Kidney Diseases Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Rare Kidney Diseases Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Rare Kidney Diseases Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Rare Kidney Diseases Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Rare Kidney Diseases Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 64. Aurinia Pharmaceuticals Company Details
Table 65. Aurinia Pharmaceuticals Business Overview
Table 66. Aurinia Pharmaceuticals Rare Kidney Diseases Treatment Product
Table 67. Aurinia Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 68. Aurinia Pharmaceuticals Recent Developments
Table 69. Sanofi Company Details
Table 70. Sanofi Business Overview
Table 71. Sanofi Rare Kidney Diseases Treatment Product
Table 72. Sanofi Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 73. Sanofi Recent Developments
Table 74. Calliditas Therapeutics AB Company Details
Table 75. Calliditas Therapeutics AB Business Overview
Table 76. Calliditas Therapeutics AB Rare Kidney Diseases Treatment Product
Table 77. Calliditas Therapeutics AB Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 78. Calliditas Therapeutics AB Recent Developments
Table 79. Shire Company Details
Table 80. Shire Business Overview
Table 81. Shire Rare Kidney Diseases Treatment Product
Table 82. Shire Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 83. Shire Recent Developments
Table 84. GSK Company Details
Table 85. GSK Business Overview
Table 86. GSK Rare Kidney Diseases Treatment Product
Table 87. GSK Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 88. GSK Recent Developments
Table 89. Amicus Therapeutics Company Details
Table 90. Amicus Therapeutics Business Overview
Table 91. Amicus Therapeutics Rare Kidney Diseases Treatment Product
Table 92. Amicus Therapeutics Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 93. Amicus Therapeutics Recent Developments
Table 94. Horizon Therapeutics Company Details
Table 95. Horizon Therapeutics Business Overview
Table 96. Horizon Therapeutics Rare Kidney Diseases Treatment Product
Table 97. Horizon Therapeutics Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 98. Horizon Therapeutics Recent Developments
Table 99. Advicenne Company Details
Table 100. Advicenne Business Overview
Table 101. Advicenne Rare Kidney Diseases Treatment Product
Table 102. Advicenne Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 103. Advicenne Recent Developments
Table 104. Reata Pharmaceuticals Company Details
Table 105. Reata Pharmaceuticals Business Overview
Table 106. Reata Pharmaceuticals Rare Kidney Diseases Treatment Product
Table 107. Reata Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 108. Reata Pharmaceuticals Recent Developments
Table 109. Alexion Pharmaceuticals Company Details
Table 110. Alexion Pharmaceuticals Business Overview
Table 111. Alexion Pharmaceuticals Rare Kidney Diseases Treatment Product
Table 112. Alexion Pharmaceuticals Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 113. Alexion Pharmaceuticals Recent Developments
Table 114. Otsuka Pharmaceutical Company Details
Table 115. Otsuka Pharmaceutical Business Overview
Table 116. Otsuka Pharmaceutical Rare Kidney Diseases Treatment Product
Table 117. Otsuka Pharmaceutical Revenue in Rare Kidney Diseases Treatment Business (2018-2023) & (US$ Million)
Table 118. Otsuka Pharmaceutical Recent Developments
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Kidney Diseases Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Rare Kidney Diseases Treatment Market Share by Type: 2022 VS 2033
Figure 3. Enzyme Replacement Therapy Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Others Features
Figure 6. Global Rare Kidney Diseases Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Rare Kidney Diseases Treatment Market Share by Application: 2022 VS 2033
Figure 8. Atypical Hemolytic Uremic Syndrome Case Studies
Figure 9. Nephropathic Cystinosis Case Studies
Figure 10. Lupus Nephritis Case Studies
Figure 11. Others Case Studies
Figure 12. Rare Kidney Diseases Treatment Report Years Considered
Figure 13. Global Rare Kidney Diseases Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Rare Kidney Diseases Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Rare Kidney Diseases Treatment Market Share by Region: 2022 VS 2033
Figure 16. Global Rare Kidney Diseases Treatment Market Share by Players in 2022
Figure 17. Global Top Rare Kidney Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Kidney Diseases Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Rare Kidney Diseases Treatment Revenue in 2022
Figure 19. North America Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Rare Kidney Diseases Treatment Market Share by Type (2018-2033)
Figure 21. North America Rare Kidney Diseases Treatment Market Share by Application (2018-2033)
Figure 22. North America Rare Kidney Diseases Treatment Market Share by Country (2018-2033)
Figure 23. United States Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Rare Kidney Diseases Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Rare Kidney Diseases Treatment Market Share by Type (2018-2033)
Figure 27. Europe Rare Kidney Diseases Treatment Market Share by Application (2018-2033)
Figure 28. Europe Rare Kidney Diseases Treatment Market Share by Country (2018-2033)
Figure 29. Germany Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Rare Kidney Diseases Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Rare Kidney Diseases Treatment Market Share by Type (2018-2033)
Figure 37. China Rare Kidney Diseases Treatment Market Share by Application (2018-2033)
Figure 38. Asia Rare Kidney Diseases Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Rare Kidney Diseases Treatment Market Share by Type (2018-2033)
Figure 40. Asia Rare Kidney Diseases Treatment Market Share by Application (2018-2033)
Figure 41. Asia Rare Kidney Diseases Treatment Market Share by Region (2018-2033)
Figure 42. Japan Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Rare Kidney Diseases Treatment Market Share by Country (2018-2033)
Figure 52. Brazil Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Rare Kidney Diseases Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Aurinia Pharmaceuticals Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 59. Sanofi Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 60. Calliditas Therapeutics AB Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 61. Shire Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 62. GSK Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 63. Amicus Therapeutics Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 64. Horizon Therapeutics Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 65. Advicenne Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 66. Reata Pharmaceuticals Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 67. Alexion Pharmaceuticals Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 68. Otsuka Pharmaceutical Revenue Growth Rate in Rare Kidney Diseases Treatment Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries